References
Smith FM, Reynolds JV, Miller N, Stephens RB, Kennedy MJ. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. Eur J Surg Oncol. 2006;32(1):55–64. https://doi.org/10.1016/j.ejso.2005.09.010.
Luna-Pérez P, Rodríguez-Ramírez S, Vega J, Sandoval E, Labastida S. Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinoma. Rev Invest Clin. 2001;53(5):388–95.
Pucciarelli S, Giandomenico F, De Paoli A, et al. Bowel function and quality of life after local excision or total mesorectal excision following chemoradiotherapy for rectal cancer. Br J Surg. 2017;104(1):138–47. https://doi.org/10.1002/bjs.10318.
Marchegiani F, Palatucci V, Capelli G, et al. Rectal sparing approach after neoadjuvant therapy in patients with rectal cancer: The preliminary results of the ReSARCh trial. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-11121-8
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
All authors declare they have no conflicts of interest
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Marchegiani, F., Spolverato, G. & Pucciarelli, S. ASO Author Reflections: Rectal Preservation After Major or Complete Clinical Response to Neoadjuvant Therapy—The Safety of Integrated Approaches. Ann Surg Oncol 29, 1890–1891 (2022). https://doi.org/10.1245/s10434-021-11123-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-11123-6